Carmine Ferrara

855 total citations
28 papers, 631 citations indexed

About

Carmine Ferrara is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Molecular Biology. According to data from OpenAlex, Carmine Ferrara has authored 28 papers receiving a total of 631 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Pulmonary and Respiratory Medicine, 10 papers in Oncology and 7 papers in Molecular Biology. Recurrent topics in Carmine Ferrara's work include Lung Cancer Treatments and Mutations (15 papers), Lung Cancer Research Studies (4 papers) and Lung Cancer Diagnosis and Treatment (4 papers). Carmine Ferrara is often cited by papers focused on Lung Cancer Treatments and Mutations (15 papers), Lung Cancer Research Studies (4 papers) and Lung Cancer Diagnosis and Treatment (4 papers). Carmine Ferrara collaborates with scholars based in Italy, United States and Germany. Carmine Ferrara's co-authors include Antônio Rossi, Cesare Gridelli, Paolo Maione, Ciro Guerriero, Dario Nicolella, Filomena Del Gaizo, Giuseppe Colantuoni, Nasser K. Altorki, Roger Keresztes and Kotha Subbaramaiah and has published in prestigious journals such as Journal of Clinical Oncology, Free Radical Biology and Medicine and Annals of Oncology.

In The Last Decade

Carmine Ferrara

27 papers receiving 608 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Carmine Ferrara Italy 12 271 234 198 144 93 28 631
Karen Zempolich United States 11 196 0.7× 94 0.4× 219 1.1× 152 1.1× 89 1.0× 18 635
David H. Johnson United States 9 204 0.8× 109 0.5× 112 0.6× 95 0.7× 52 0.6× 12 497
Kristina Lamberg Sweden 13 414 1.5× 427 1.8× 194 1.0× 43 0.3× 139 1.5× 20 789
Reiko Dehari Japan 7 250 0.9× 89 0.4× 273 1.4× 91 0.6× 146 1.6× 15 852
M Paesmans Belgium 5 225 0.8× 196 0.8× 159 0.8× 48 0.3× 75 0.8× 6 455
Emily J. Greenspan United States 14 225 0.8× 69 0.3× 273 1.4× 41 0.3× 141 1.5× 22 626
JI Epstein United States 4 202 0.7× 200 0.9× 334 1.7× 31 0.2× 120 1.3× 6 598
Li‐Yan Khor United States 13 173 0.6× 339 1.4× 244 1.2× 42 0.3× 143 1.5× 13 532
Ronald Drengler United States 13 487 1.8× 104 0.4× 296 1.5× 44 0.3× 70 0.8× 27 701
H Harvey United States 11 532 2.0× 108 0.5× 213 1.1× 24 0.2× 119 1.3× 18 840

Countries citing papers authored by Carmine Ferrara

Since Specialization
Citations

This map shows the geographic impact of Carmine Ferrara's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Carmine Ferrara with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Carmine Ferrara more than expected).

Fields of papers citing papers by Carmine Ferrara

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Carmine Ferrara. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Carmine Ferrara. The network helps show where Carmine Ferrara may publish in the future.

Co-authorship network of co-authors of Carmine Ferrara

This figure shows the co-authorship network connecting the top 25 collaborators of Carmine Ferrara. A scholar is included among the top collaborators of Carmine Ferrara based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Carmine Ferrara. Carmine Ferrara is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ferrara, Carmine, et al.. (2025). Fairness-aware practices from developers’ perspective: A survey. Information and Software Technology. 182. 107710–107710. 4 indexed citations
2.
Ferrara, Carmine, et al.. (2024). ReFAIR: Toward a Context-Aware Recommender for Fairness Requirements Engineering. 1–12. 5 indexed citations
3.
4.
Ferrara, Carmine, et al.. (2023). Fairness-aware machine learning engineering: how far are we?. Empirical Software Engineering. 29(1). 9–9. 20 indexed citations
5.
Casaluce, Francesca, Assunta Sgambato, Paolo Maione, et al.. (2013). ALK inhibitors: a new targeted therapy in the treatment of advanced NSCLC. Targeted Oncology. 8(1). 55–67. 62 indexed citations
6.
Guerriero, Giulia, Carmine Ferrara, & Gaetano Ciarcia. (2012). From Rainbow Trout Skin Biopsy to Potential Adverse Health Effects Assessment. Free Radical Biology and Medicine. 53. S135–S135. 1 indexed citations
7.
Rossi, Antônio, Paolo Maione, Giuseppe Colantuoni, et al.. (2009). Recent Developments of Targeted Therapies in the Treatment of Non-Small Cell Lung Cancer. Current Drug Discovery Technologies. 6(2). 91–102. 22 indexed citations
8.
Gridelli, Cesare, Paolo Maione, Domenico Galetta, et al.. (2007). Three Cases of Long-Lasting Tumor Control with Erlotinib after Progression with Gefitinib in Advanced Non-Small Cell Lung Cancer. Journal of Thoracic Oncology. 2(8). 758–761. 24 indexed citations
9.
Gridelli, Cesare, Carmine Ferrara, Ciro Guerriero, et al.. (2007). Informal Caregiving Burden in Advanced Non-small Cell Lung Cancer: The HABIT study. Journal of Thoracic Oncology. 2(6). 475–480. 21 indexed citations
10.
Gridelli, Cesare, Antônio Rossi, Paolo Maione, et al.. (2007). Erlotinib in non-small-cell lung cancer. Expert Opinion on Pharmacotherapy. 8(15). 2579–2592. 9 indexed citations
11.
Gridelli, Cesare, Paolo Maione, Antônio Rossi, et al.. (2006). Chemotherapy of advanced NSCLC in special patient population. Annals of Oncology. 17. v72–v78. 16 indexed citations
12.
Gridelli, Cesare, Paolo Maione, Antônio Rossi, et al.. (2006). Targeted therapies in the treatment of advanced non-small cell lung cancer elderly patients. Targeted Oncology. 1(1). 13–22. 1 indexed citations
13.
Rossi, Antônio, Domenico Galetta, Paolo Maione, et al.. (2005). Italian clinical research in non-small-cell lung cancer. Annals of Oncology. 16. iv110–iv115. 3 indexed citations
14.
Rossi, Antônio, et al.. (2005). Chemotherapy of Breast Cancer in the Elderly. Current Medicinal Chemistry. 12(3). 297–310. 24 indexed citations
15.
Rossi, Antônio, Paolo Maione, Giuseppe Colantuoni, et al.. (2005). Screening for lung cancer: New horizons?. Critical Reviews in Oncology/Hematology. 56(3). 311–320. 16 indexed citations
16.
Rossi, Antônio, Paolo Maione, Giuseppe Colantuoni, et al.. (2005). Treatment of Small Cell Lung Cancer in the Elderly. The Oncologist. 10(6). 399–411. 30 indexed citations
17.
Maione, Paolo, et al.. (2004). The role of targeted therapy in non-small cell lung cancer. Critical Reviews in Oncology/Hematology. 51(1). 29–44. 23 indexed citations
18.
Gridelli, Cesare, Paolo Maione, Antônio Rossi, et al.. (2003). E-34. Chemotherapy for non-small cell lung cancer in the elderly. Lung Cancer. 41. S43–S44. 1 indexed citations
19.
Giovagnoni, Andrea, Gianluca Valeri, & Carmine Ferrara. (2002). MRI of esophageal cancer. Abdominal Imaging. 27(4). 361–366. 9 indexed citations
20.
Folgore, A, et al.. (1997). Effects of alpha-adrenergic agonists on Toxoplasma gondii replication in human umbilical vein endothelial cells.. PubMed. 45(1). 9–18. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Karen Zempolich Breakdown of academic impact, for papers by David H. Johnson Breakdown of academic impact, for papers by Kristina Lamberg Breakdown of academic impact, for papers by Reiko Dehari Breakdown of academic impact, for papers by M Paesmans Breakdown of academic impact, for papers by Emily J. Greenspan Breakdown of academic impact, for papers by JI Epstein Breakdown of academic impact, for papers by Li‐Yan Khor Breakdown of academic impact, for papers by Ronald Drengler Breakdown of academic impact, for papers by H Harvey
Rankless by CCL
2026